United States - English - NLM (National Library of Medicine)

sun pharmaceutical industries limited - cephalexin (unii: obn7uds42y) (cephalexin - unii:obn7uds42y) - cephalexin 250 mg

United States - English - NLM (National Library of Medicine)

unit dose services - cephalexin (unii: obn7uds42y) (cephalexin anhydrous - unii:5sff1w6677) - cephalexin anhydrous 250 mg - cephalexin capsules, usp are indicated for the treatment of the following infections when caused by susceptible strains of the designated microorganisms:   respiratory tract infections caused by and (penicillin is the usual drug of choice in the treatment and prevention of streptococcal infections, including the prophylaxis of rheumatic fever.   cephalexin capsules, usp are generally effective in the eradication of streptococci from the nasopharynx; however, substantial data establishing the efficacy of cephalexin capsules, usp in the subsequent prevention of rheumatic fever are not available at present.)   otitis media due to , , , and   skin and skin structure infections caused by and/or   bone infections caused by and/or   genitourinary tract infections, including acute prostatitis, caused by , , and   — culture and susceptibility tests should be initiated prior to and during therapy. renal function studies should be performed when indicated.   to reduce the development of drug-resistant bacteria and maint

United States - English - NLM (National Library of Medicine)

rebel distributors corp - cephalexin (unii: obn7uds42y) (cephalexin anhydrous - unii:5sff1w6677) - cephalexin anhydrous 500 mg - cephalexin capsules, usp are indicated for the treatment of the following infections when caused by susceptible strains of the designated microorganisms: respiratory tract infections caused by streptococcus pneumoniae and streptococcus pyogenes (penicillin is the usual drug of choice in the treatment and prevention of streptococcal infections, including the prophylaxis of rheumatic fever. cephalexin capsules, usp are generally effective in the eradication of streptococci from the nasopharynx; however, substantial data establishing the efficacy of cephalexin capsules, usp in the subsequent prevention of rheumatic fever are not available at present.) otitis media due to streptococcus pneumoniae , haemophilus influenzae , staphylococcus aureus, treptococcus pyogenes , and moraxella catarrhalis skin and skin structure infections caused by staphylococcus aureus and/or streptococcus yogenes bone infections caused by staphylococcus aureus and/or proteus mirabilis   genitourinary tract infections, including acute

United States - English - NLM (National Library of Medicine)

state of florida doh central pharmacy - cephalexin (unii: obn7uds42y) (cephalexin anhydrous - unii:5sff1w6677) - cephalexin anhydrous 500 mg - cephalexin capsules, usp are indicated for the treatment of the following infections when caused by susceptible strains of the designated microorganisms:   respiratory tract infections caused by streptococcus pneumoniae and streptococcus pyogenes (penicillin is the usual drug of choice in the treatment and prevention of streptococcal infections, including the prophylaxis of rheumatic fever.   cephalexin capsules, usp are generally effective in the eradication of streptococci from the nasopharynx; however, substantial data establishing the efficacy of cephalexin capsules, usp in the subsequent prevention of rheumatic fever are not available at present.)   otitis media due to streptococcus pneumoniae , haemophilus influenzae , staphylococcus aureus, streptococcus pyogenes , and moraxella catarrhalis   skin and skin structure infections caused by staphylococcus aureus and/or streptococcus pyogenes   bone infections caused by staphylococcus aureus an

United States - English - NLM (National Library of Medicine)

aidarex pharmaceuticals llc - cephalexin anhydrous (unii: 5sff1w6677) (cephalexin anhydrous - unii:5sff1w6677) - cephalexin anhydrous 250 mg

United States - English - NLM (National Library of Medicine)

physicians total care, inc. - oxaprozin (unii: mhj80w9lrb) (oxaprozin - unii:mhj80w9lrb) - oxaprozin 600 mg - carefully consider the potential benefits and risks of oxaprozin tablet, usp and other treatment options before deciding to use oxaprozin tablet, usp. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings). oxaprozin tablet, usp is indicated: - for relief of the signs and symptoms of osteoarthritis - for relief of the signs and symptoms of rheumatoid arthritis - for relief of the signs and symptoms of juvenile rheumatoid arthritis oxaprozin tablet, usp is contraindicated in patients with known hyper-sensitivity to oxaprozin. oxaprozin tablet, usp should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other nsaids. severe, rarely fatal, anaphylactic-like reactions to nsaids have been reported in such patients (see warnings, anaphylactoid reactions and precautions, preexisting asthma). oxaprozin tablet, usp is contraindicated for the treatment of peri-operative pain in

United States - English - NLM (National Library of Medicine)

sun pharma global fze - pantoprazole sodium (unii: 6871619q5x) (pantoprazole - unii:d8tst4o562) - pantoprazole 40 mg

United States - English - NLM (National Library of Medicine)

mckesson contract packaging - promethazine hydrochloride (unii: r61zeh7i1i) (promethazine - unii:ff28ejq494) - promethazine hydrochloride 25 mg

United States - English - NLM (National Library of Medicine)

dispensing solutions inc. - topiramate (unii: 0h73wjj391) (topiramate - unii:0h73wjj391) - topiramate 25 mg - topiramate tablets are indicated as initial monotherapy in patients 10 years of age and older with partial onset or primary generalized tonic-clonic seizures. effectiveness was demonstrated in a controlled trial in patients with epilepsy who had no more than 2 seizures in the 3 months prior to enrollment. safety and effectiveness in patients who were converted to monotherapy from a previous regimen of other anticonvulsant drugs have not been established in controlled trials. topiramate tablets are indicated as adjunctive therapy for adults and pediatric patients ages 2 to 16 years with partial onset seizures, or primary generalized tonic-clonic seizures, and in patients 2 years of age and older with seizures associated with lennox-gastaut syndrome. topiramate tablets are contraindicated in patients with a history of hypersensitivity to any component of this product. the abuse and dependence potential of topiramate has not been evaluated in human studies.

United States - English - NLM (National Library of Medicine)

h.j. harkins company, inc. - tramadol hydrochloride (unii: 9n7r477wck) (tramadol - unii:39j1lgj30j), acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d) - tramadol hydrochloride 37.5 mg - tramadol hydrochloride and acetaminophen tablet is indicated for the short-term (five days or less) management of acute pain. tramadol hydrochloride and acetaminophen tablet should not be administered to patients who have previously demonstrated hypersensitivity to tramadol, acetaminophen, any other component of this product or opioids. tramadol hydrochloride and acetaminophen tablet is contraindicated in any situation where opioids are contraindicated, including acute intoxication with any of the following: alcohol, hypnotics, narcotics, centrally acting analgesics, opioids or psychotropic drugs. tramadol hydrochloride and acetaminophen tablet may worsen central nervous system and respiratory depression in these patients. tramadol has mu-opioid agonist activity. tramadol hydrochloride and acetaminophen tablet, a tramadol-containing product, can be abused and may be subject to criminal diversion. addiction is a primary, chronic, neurobiologic disease, with genetic, psychosocial, and environmental factors infl